These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24816846)

  • 1. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
    Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
    PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
    Liu H; Li M; Song Y; Xu W
    Front Immunol; 2018; 9():2479. PubMed ID: 30410495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARD9 mediates T cell inflammatory response in Coxsackievirus B3-induced acute myocarditis.
    Sun C; Zhang X; Yu Y; Li Z; Xie Y
    Cardiovasc Pathol; 2020; 49():107261. PubMed ID: 32771878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced myocarditis following Coxsackievirus infection in cellular FLICE inhibitory protein--long form-transgenic mice.
    Huber S; Dohrman A; Sartini D; Budd RC
    Immunology; 2006 Dec; 119(4):541-50. PubMed ID: 17010108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c-FLIPL cleavage product p43FLIP promotes activation of extracellular signal-regulated kinase (ERK), nuclear factor κB (NF-κB), and caspase-8 and T cell survival.
    Koenig A; Buskiewicz IA; Fortner KA; Russell JQ; Asaoka T; He YW; Hakem R; Eriksson JE; Budd RC
    J Biol Chem; 2014 Jan; 289(2):1183-91. PubMed ID: 24275659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication
    Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R
    Front Immunol; 2020; 11():603437. PubMed ID: 33519812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
    Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
    Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.
    Zhang QM; Song WQ; Li YJ; Qian J; Zhai AX; Wu J; Li AM; He JM; Zhao JY; Yu X; Wei LL; Zhang FM
    Virol J; 2012 Dec; 9():312. PubMed ID: 23249700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3.
    Burke JD; Sonenberg N; Platanias LC; Fish EN
    Antivir Ther; 2011; 16(4):577-84. PubMed ID: 21685545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis.
    Wu R; Wu T; Li P; Wang Q; Shi Y; Zhan Y; Zhang S; Xia T; Wang Z; Lv H
    Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
    Callon D; Glenet M; Lebreil AL; Heng L; Bouland N; Fichel C; Fornes P; Andreoletti L; Berri F
    PLoS Pathog; 2024 May; 20(5):e1012125. PubMed ID: 38696536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
    Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
    Wang Y; Gao B; Xiong S
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
    Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
    Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
    Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
    PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.